11/19
09:14 am
cvkd
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook [Yahoo! Finance]
Medium
Report
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook [Yahoo! Finance]
11/19
09:00 am
cvkd
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
Medium
Report
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
11/12
09:00 am
cvkd
CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
Medium
Report
CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
11/11
01:23 pm
cvkd
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) had its price target raised by analysts at HC Wainwright from $3.00 to $32.00. They now have a "buy" rating on the stock.
Medium
Report
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) had its price target raised by analysts at HC Wainwright from $3.00 to $32.00. They now have a "buy" rating on the stock.
11/7
09:00 am
cvkd
CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE
Medium
Report
CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE
11/1
08:04 pm
cvkd
Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds [Yahoo! Finance]
High
Report
Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds [Yahoo! Finance]
11/1
08:00 pm
cvkd
Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
High
Report
Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
10/28
08:51 am
cvkd
We're Keeping An Eye On Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Keeping An Eye On Cadrenal Therapeutics' (NASDAQ:CVKD) Cash Burn Rate [Yahoo! Finance]
10/24
09:00 am
cvkd
Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility
High
Report
Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility
10/23
09:00 am
cvkd
CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM
Medium
Report
CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM
9/23
04:15 pm
cvkd
Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference
High
Report
Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference